InvestorsHub Logo
Followers 10
Posts 1358
Boards Moderated 0
Alias Born 12/03/2015

Re: Spider Web post# 58820

Sunday, 05/21/2017 6:06:05 PM

Sunday, May 21, 2017 6:06:05 PM

Post# of 195071
OVER VALUED

Most are obviously selling every chance they can get. Especially when the volume allows. This is reflected in the lack of buyers and the frailing pps. I would never buy at this level. I would not even consider buying until the risk level is diminished to around $0.005. And even then, it would still only be a consideration.

Heavy Dilution through Equity Financing is inevitable here. There is no way out of that. They need it in order to overcome the weak start-up in their Smart Medical Alliance Venture, and MSO Contracts. Because the script growth has topped-out and now showing contraction. It would be smart to just hold off from being inappropriately influenced to buy now. The pps would then take care of itself, by grinding down into the $0.005 area with no problem at all. This would then eliminate "most" downside risk.

And they are not going to Up-Grade soon. That will take much longer, especially after breaking down below 0.01 again. Then, after the Dilutive Equity Finance Package is complete, they can start building towards a small OTC Up-Grade. But this will take another year or so, no doubt. By then, the pps may climb back to $0.02. Then after the Reverse-Split is complete, I would then wait until the pps settles down again before re-evaluating.


JMO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News